Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06216301
Status:
RECRUITING
Last Update Posted:
2024-01-22
First Post:
2023-12-29
Brief Title:
LUNAR-2 TTFields With Pembrolizumab Platinum-based Chemotherapy for Metastatic NSCLC
Sponsor:
NovoCure GmbH
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF-44
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None